Oramed Pharmaceuticals Inc. logo

Oramed Pharmaceuticals Inc.

NASDAQ:ORMP

Overview | Financials
Company Name Oramed Pharmaceuticals Inc.
Symbol ORMP
Currency USD
Price 2.35
Market Cap 95,807,150
Dividend Yield 0%
52-week-range 1.67 - 3.67
Industry Biotechnology
Sector Healthcare
CEO Mr. Nadav Kidron Esq.
Website https://www.oramed.com

An error occurred while fetching data.

About Oramed Pharmaceuticals Inc.

Oramed Pharmaceuticals Inc. engages in the research and development of pharmaceutical solutions for the treatment of diabetes and for the use of orally ingestible capsules or pills for delivery of polypeptides. Its proprietary flagship product is the ORMD-0801, an orally ingestible insulin capsule, which completed phase II clinical trials for

Related Stocks

Harrow Health, Inc. logo

Harrow Health, Inc.

HROW

37.98 USD

Viking Therapeutics, Inc. logo

Viking Therapeutics, Inc.

VKTX

54.13 USD

XBiotech Inc. logo

XBiotech Inc.

XBIT

6.52 USD

Scholar Rock Holding Corporation logo

Scholar Rock Holding Corporation

SRRK

8.03 USD

Talkspace, Inc. logo

Talkspace, Inc.

TALK

1.79 USD

Profound Medical Corp. logo

Profound Medical Corp.

PROF

8.2 USD

Fusion Pharmaceuticals Inc. logo

Fusion Pharmaceuticals Inc.

FUSN

21.55 USD

Financials

Numbers are in millions USD

Numbers are in millions USD